Manon Rhéaume

Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061

Montse Llinàs‐Brunet, Murray D. Bailey, Gordon T. Bolger et al. · Journal of Medicinal Chemistry · 2004 · 186 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

The Liver Partition Coefficient-Corrected Inhibitory Quotient and the Pharmacokinetic-Pharmacodynamic Relationship of Directly Acting Anti-Hepatitis C Virus Agents in Humans

Jianmin Duan, Gordon T. Bolger, Michel Garneau et al. · Antimicrobial Agents and Chemotherapy · 2012 · 20 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis

Gordon T. Bolger, Nicole Lapeyre, Manon Rhéaume et al. · Antiviral Research · 1999 · 15 citations

Life Sciences, Infectious Diseases, Microbiology +11

Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor

Jianmin Duan, Chan‐Loi Yong, Michel Garneau et al. · Xenobiotica · 2011 · 15 citations

Pharmacy, Pharmacokinetics, Pharmacology +17